ID

38563

Descrizione

Study ID: 110948 Clinical Study ID: 110948 Study Title: Assessment of the effect of sumatriptan and naproxen sodium combination tablet, sumatriptan tablet, and naproxen sodium tablet treatment on blood pressure when administered intermittently for six months for the acute treatment of migraine attacks, with or without aura, in adults Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00792636 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: sumatriptan and naproxen sodium combination tablet Trade Name: sumatriptan tablet, naproxen sodium tablet Study Indication: Migraine Disorders

Keywords

  1. 24/10/19 24/10/19 -
  2. 24/10/19 24/10/19 -
Titolare del copyright

GlaxoSmithKline

Caricato su

24 ottobre 2019

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Sumatriptan and Naproxen Sodium for Acute Treatment of Migraine Attacks; NCT00792636

End of Study

  1. StudyEvent: ODM
    1. End of Study
Administrative Data
Descrizione

Administrative Data

Alias
UMLS CUI-1
C1320722
Site
Descrizione

Study Site

Tipo di dati

text

Alias
UMLS CUI [1]
C2825164
Patient
Descrizione

Patient name

Tipo di dati

text

Alias
UMLS CUI [1]
C1299487
Patient No
Descrizione

Patients, Identification number

Tipo di dati

integer

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1300638
Date of Visit/Assessment
Descrizione

Date of Visit/Assessment

Alias
UMLS CUI-1
C1320303
UMLS CUI-2
C2985720
Date of visit/assessment
Descrizione

Date of visit; Assessment Date

Tipo di dati

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
Pharmacogenetic (PGx) Research Withdrawal of Consent
Descrizione

Pharmacogenetic (PGx) Research Withdrawal of Consent

Alias
UMLS CUI-1
C2347500
UMLS CUI-2
C0021430
UMLS CUI-3
C2349954
Has subject withdrawn consent for PGx research?
Descrizione

Pharmacogenetic Test, Informed Consent, Withdraw

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C2349954
Yes, date informed consent withdrawn
Descrizione

Pharmacogenetic Test, Informed Consent, Withdraw, Date in time

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C2349954
UMLS CUI [1,4]
C0011008
Has a request been made for blood sample destruction?
Descrizione

Pharmacogenetic Test, Blood specimen, Destruction, Request

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C1948029
UMLS CUI [1,4]
C1272683
Yes, check reason
Descrizione

Pharmacogenetic Test, Blood specimen, Destruction, Request, Reason and justification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C1948029
UMLS CUI [1,4]
C1272683
UMLS CUI [1,5]
C0566251
Other, specify
Descrizione

Pharmacogenetic Test, Blood specimen, Destruction, Request, Reason and justification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2347500
UMLS CUI [1,2]
C0178913
UMLS CUI [1,3]
C1948029
UMLS CUI [1,4]
C1272683
UMLS CUI [1,5]
C0566251
Status of Treatment Blind
Descrizione

Status of Treatment Blind

Alias
UMLS CUI-1
C2347038
UMLS CUI-2
C0449438
Was the treatment blind broken during the study?
Descrizione

Blinded Clinical Study, Subject Unblinding Event Record

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C2347038
UMLS CUI [1,2]
C3897431
Yes, Date blind broken
Descrizione

Blinded Clinical Study, Subject Unblinding Event Record, Date in time

Tipo di dati

date

Alias
UMLS CUI [1,1]
C2347038
UMLS CUI [1,2]
C3897431
UMLS CUI [1,3]
C0011008
Yes, Reason blind broken
Descrizione

Blinded Clinical Study, Subject Unblinding Event Record, Reason and justification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2347038
UMLS CUI [1,2]
C3897431
UMLS CUI [1,3]
C0566251
Other, specify
Descrizione

Blinded Clinical Study, Subject Unblinding Event Record, Reason and justification

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2347038
UMLS CUI [1,2]
C3897431
UMLS CUI [1,3]
C0566251
Medical Device Question
Descrizione

Medical Device Question

Alias
UMLS CUI-1
C0025080
UMLS CUI-2
C1522634
Did the subject experience an incident or near incident with GSK medical devices provided for use during this study?
Descrizione

Medical Devices, Incident

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0025080
UMLS CUI [1,2]
C1551358
Pregnancy Information
Descrizione

Pregnancy Information

Alias
UMLS CUI-1
C0032961
UMLS CUI-2
C1533716
Did the subject become pregnant during the study?
Descrizione

Pregnancy, During, Clinical Trials

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0347984
UMLS CUI [1,3]
C0008976
Study Conclusion
Descrizione

Study Conclusion

Alias
UMLS CUI-1
C0008976
UMLS CUI-2
C1707478
Date of subject completion or withdrawal
Descrizione

Completion Status, Date in time; Withdraw, Date in time

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0805732
UMLS CUI [1,2]
C0011008
UMLS CUI [2,1]
C2349954
UMLS CUI [2,2]
C0011008
Was the subject withdrawn from the study?
Descrizione

Patient withdrawn from trial

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0422727
Yes, Primary reason for withdrawal
Descrizione

Patient withdrawn from trial, Reason and justification, Primary

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0566251
UMLS CUI [1,3]
C0205225
Specify
Descrizione

Patient withdrawn from trial, Reason and justification, Primary

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0422727
UMLS CUI [1,2]
C0566251
UMLS CUI [1,3]
C0205225
For Data Managers or Monitors only: Tick or untick this box to require the investigator to re-sign the case book
Descrizione

Clinical study case, Investigator Signature

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1706256
UMLS CUI [1,2]
C2346576

Similar models

End of Study

  1. StudyEvent: ODM
    1. End of Study
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Study Site
Item
Site
text
C2825164 (UMLS CUI [1])
Patient name
Item
Patient
text
C1299487 (UMLS CUI [1])
Patients, Identification number
Item
Patient No
integer
C0030705 (UMLS CUI [1,1])
C1300638 (UMLS CUI [1,2])
Item Group
Date of Visit/Assessment
C1320303 (UMLS CUI-1)
C2985720 (UMLS CUI-2)
Date of visit; Assessment Date
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
Item Group
Pharmacogenetic (PGx) Research Withdrawal of Consent
C2347500 (UMLS CUI-1)
C0021430 (UMLS CUI-2)
C2349954 (UMLS CUI-3)
Pharmacogenetic Test, Informed Consent, Withdraw
Item
Has subject withdrawn consent for PGx research?
boolean
C2347500 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,3])
Pharmacogenetic Test, Informed Consent, Withdraw, Date in time
Item
Yes, date informed consent withdrawn
date
C2347500 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,3])
C0011008 (UMLS CUI [1,4])
Pharmacogenetic Test, Blood specimen, Destruction, Request
Item
Has a request been made for blood sample destruction?
boolean
C2347500 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
Item
Yes, check reason
text
C2347500 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C0566251 (UMLS CUI [1,5])
CL Item
Subject withdrew consent for PGx  (1)
CL Item
Screen failure (2)
CL Item
Other, specify (3)
Pharmacogenetic Test, Blood specimen, Destruction, Request, Reason and justification
Item
Other, specify
text
C2347500 (UMLS CUI [1,1])
C0178913 (UMLS CUI [1,2])
C1948029 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,4])
C0566251 (UMLS CUI [1,5])
Item Group
Status of Treatment Blind
C2347038 (UMLS CUI-1)
C0449438 (UMLS CUI-2)
Blinded Clinical Study, Subject Unblinding Event Record
Item
Was the treatment blind broken during the study?
boolean
C2347038 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
Blinded Clinical Study, Subject Unblinding Event Record, Date in time
Item
Yes, Date blind broken
date
C2347038 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Item
Yes, Reason blind broken
text
C2347038 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other, specify (2)
Blinded Clinical Study, Subject Unblinding Event Record, Reason and justification
Item
Other, specify
text
C2347038 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
Item Group
Medical Device Question
C0025080 (UMLS CUI-1)
C1522634 (UMLS CUI-2)
Medical Devices, Incident
Item
Did the subject experience an incident or near incident with GSK medical devices provided for use during this study?
boolean
C0025080 (UMLS CUI [1,1])
C1551358 (UMLS CUI [1,2])
Item Group
Pregnancy Information
C0032961 (UMLS CUI-1)
C1533716 (UMLS CUI-2)
Pregnancy, During, Clinical Trials
Item
Did the subject become pregnant during the study?
boolean
C0032961 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
Item Group
Study Conclusion
C0008976 (UMLS CUI-1)
C1707478 (UMLS CUI-2)
Completion Status, Date in time; Withdraw, Date in time
Item
Date of subject completion or withdrawal
date
C0805732 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C2349954 (UMLS CUI [2,1])
C0011008 (UMLS CUI [2,2])
Patient withdrawn from trial
Item
Was the subject withdrawn from the study?
boolean
C0422727 (UMLS CUI [1])
Item
Yes, Primary reason for withdrawal
text
C0422727 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
Code List
Yes, Primary reason for withdrawal
CL Item
Adverse Event - No subreasons (1)
CL Item
Adverse Event - Subject met the GSK defined Liver Chemistry Stopping Criteria (2)
CL Item
Lack of efficacy  (3)
CL Item
Protocol deviation - No subreasons (4)
CL Item
Protocol deviation - Subject failed to provide T-SMBP measurements for 2 migraine attacks per month  (5)
CL Item
Protocol deviation - Prohibited medication use (6)
CL Item
Protocol deviation - New information about subject's history violates inclusion/exclusion criteria (7)
CL Item
Protocol deviation - New information about subject's meds violates inclusion/exclusion criteria  (8)
CL Item
Protocol deviation - Glycosylated hemoglobin >=8.0 (9)
CL Item
Subject reached protocol defined stopping criteria - No subreasons (9)
CL Item
Subject reached protocol defined stopping criteria - Monthly avg BP >= 140/90 mmHg on T-SMBP confirmed by rpt measurement in clinic (10)
CL Item
Subject reached protocol defined stopping criteria - Monthly avg incr >= 30 mmHg Sys or >= 20 mmHg Dia from in-clinic screening BP on T-SMBP confirmed in clinic (11)
CL Item
Subject reached protocol defined stopping criteria - Sys BP >=140 mmHg or Dia BP >= 90 mm Hg on consecutive visits at least 2wks apart (12)
CL Item
Subject reached protocol defined stopping criteria - Pregnancy (13)
CL Item
Subject reached protocol defined stopping criteria - Insufficient attacks(After first 3 months of treatment period, subject has treated on average <2 migraine attacks/month)  (14)
CL Item
Study closed/terminated (15)
CL Item
Lost to follow-up (15)
CL Item
Investigator discretion, specify  (16)
CL Item
Withdrew consent, Specify (17)
Patient withdrawn from trial, Reason and justification, Primary
Item
Specify
text
C0422727 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
C0205225 (UMLS CUI [1,3])
Clinical study case, Investigator Signature
Item
For Data Managers or Monitors only: Tick or untick this box to require the investigator to re-sign the case book
boolean
C1706256 (UMLS CUI [1,1])
C2346576 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial